跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BECONASE ALLERGY & HAYFEVER beclometasone dipropionate 0.5mg/g (50 micrograms per actuation) aqueous nasal spray bottle - TGA Drug Approval Details
Approvals
/
TGA
/
BECONASE ALLERGY & HAYFEVER beclometasone dipropionate 0.5mg/g (50 micrograms per actuation) aqueous nasal spray bottle
Approved
STANDARD
BECONASE ALLERGY & HAYFEVER beclometasone dipropionate 0.5mg/g (50 micrograms per actuation) aqueous nasal spray bottle
Viatris Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 31, 2025
Approval ID
13b2f7f646fdbbac
Company
Viatris Pty Ltd
Type
Standard
Approval Details
Approval Id
13b2f7f646fdbbac
Product Name
BECONASE ALLERGY & HAYFEVER beclometasone dipropionate 0.5mg/g (50 micrograms per actuation) aqueous nasal spray bottle
Artg Id
72345
Artg Name
BECONASE ALLERGY & HAYFEVER beclometasone dipropionate 0.5mg/g (50 micrograms per actuation) aqueous nasal spray bottle
Sponsor
Viatris Pty Ltd
Company Detail Path
/organization/viatris-pty-ltd
Artg Date
1999-12-16
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/46e0f48988242640703987613794e368.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 31, 2025
Approval ID
13b2f7f646fdbbac
Type
Standard
Back to TGA Approvals